- Home
- KALV vs ZKH Comparison
KALV vs ZKH Comparison
Compare KALV & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- ZKH
- Stock Information
- Founded
- KALV N/A
- ZKH 1998
- Country
- KALV United States
- ZKH China
- Employees
- KALV N/A
- ZKH N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- ZKH
- Sector
- KALV Health Care
- ZKH
- Exchange
- KALV Nasdaq
- ZKH Nasdaq
- Market Cap
- KALV 563.1M
- ZKH 523.9M
- IPO Year
- KALV N/A
- ZKH 2023
- Fundamental
- Price
- KALV $12.00
- ZKH $2.92
- Analyst Decision
- KALV Strong Buy
- ZKH Buy
- Analyst Count
- KALV 8
- ZKH 1
- Target Price
- KALV $24.83
- ZKH $4.00
- AVG Volume (30 Days)
- KALV 729.1K
- ZKH 57.8K
- Earning Date
- KALV 03-12-2025
- ZKH 05-20-2025
- Dividend Yield
- KALV N/A
- ZKH N/A
- EPS Growth
- KALV N/A
- ZKH N/A
- EPS
- KALV N/A
- ZKH N/A
- Revenue
- KALV N/A
- ZKH $1,200,328,532.00
- Revenue This Year
- KALV N/A
- ZKH $11.95
- Revenue Next Year
- KALV N/A
- ZKH $11.23
- P/E Ratio
- KALV N/A
- ZKH N/A
- Revenue Growth
- KALV N/A
- ZKH 0.46
- 52 Week Low
- KALV $7.30
- ZKH $2.62
- 52 Week High
- KALV $15.50
- ZKH $14.48
- Technical
- Relative Strength Index (RSI)
- KALV 55.34
- ZKH 31.82
- Support Level
- KALV $11.42
- ZKH $2.86
- Resistance Level
- KALV $12.35
- ZKH $3.08
- Average True Range (ATR)
- KALV 0.96
- ZKH 0.20
- MACD
- KALV 0.04
- ZKH -0.04
- Stochastic Oscillator
- KALV 88.74
- ZKH 8.11
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.